Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease

Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease

Abstract Evidence from epidemiological literature on the association of circulating micronutrients with risk of nonalcoholic fatty liver disease (NAFLD) is inconsistent. We aimed to elucidate the causal relationships using Mendelian randomization (MR). Single-nucleotide polymorphisms associated with...

Full description

Bibliographic Details
Main Authors:	Ke Liu, Ying Chen, Jiaxin Chen, Weiwei Chen, Xiaohui Sun, Yingying Mao, Ding Ye
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-01-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-024-51609-3

Similar Items

Micronutrients in Nonalcoholic Fatty Liver Disease PathogenesisSummary
by: Octavia Pickett-Blakely, et al.
Published: (2018-01-01)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Waseem Amjad, et al.
Published: (2023-08-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

Genetic predisposition in nonalcoholic fatty liver disease
by: Silvia Sookoian, et al.
Published: (2017-03-01)

Lean nonalcoholic fatty liver disease and sarcopenia
by: Milian Chen, et al.
Published: (2023-06-01)

Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease.
by: Chia-Hung Chiang, et al.
Published: (2012-01-01)

Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis
by: Vincent L. Chen, et al.
Published: (2019-08-01)

An endocrine perspective of nonalcoholic fatty liver disease (NAFLD)
by: Romina Lomonaco, et al.
Published: (2011-10-01)

The Relationship between Nonalcoholic Fatty Liver Disease and Retinopathy in NHANES III.
by: Tzu-Yu Lin, et al.
Published: (2016-01-01)

Role of extracellular vesicles in nonalcoholic fatty liver disease
by: Wei Jiang, et al.
Published: (2023-07-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023-02-01)

A review of nonalcoholic fatty liver disease - genetics and animal models
by: Ze Zheng, et al.
Published: (2016-01-01)

Nonalcoholic Fatty Liver Disease and Ayurveda
by: Sanjeev Sharma, et al.
Published: (2023-01-01)

History of Nonalcoholic Fatty Liver Disease
by: Amedeo Lonardo, et al.
Published: (2020-08-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Treatment of nonalcoholic fatty liver disease
by: Paul Angulo, MD
Published: (2002-01-01)

Leptin in nonalcoholic fatty liver disease
by: Billur Canbakan, et al.
Published: (2008-07-01)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
by: Niu S, et al.
Published: (2023-08-01)

Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
by: Zhongwei Zhou, et al.
Published: (2017-09-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Nonalcoholic fatty liver disease stratification by liver lipidomics
by: Olga Vvedenskaya, et al.
Published: (2021-01-01)

Genetic Evidence for the Causal Association of Circulating Cytokines and Growth Factors With Coronary Artery Disease
by: Yuwei Li, et al.
Published: (2024-01-01)

Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease
by: Hua Jiang, et al.
Published: (2023-09-01)

The impact of obstructive sleep apnea on nonalcoholic fatty liver disease
by: Haiying Tang, et al.
Published: (2023-10-01)

Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease
by: Xu Chen, et al.
Published: (2021-09-01)

Aberrant Hepatic MicroRNA Expression in Nonalcoholic Fatty Liver Disease
by: Yue Ying Feng, et al.
Published: (2014-11-01)

Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
by: Jiaqin Yuan, et al.
Published: (2024-02-01)

The additive effect of genetic and metabolic factors in the pathogenesis of nonalcoholic fatty liver disease
by: Yuya Seko, et al.
Published: (2022-10-01)

The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study
by: Goh Eun Chung, et al.
Published: (2020-10-01)

Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality
by: Hui Han, et al.
Published: (2024-03-01)

The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease
by: Pengyan Fa, et al.
Published: (2023-11-01)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
by: Niu S, et al.
Published: (2023-09-01)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
by: Yuzhen Zhao, et al.
Published: (2019-12-01)

Serum metabolomic analysis of the effect of exercise on nonalcoholic fatty liver disease
by: Jia Li, et al.
Published: (2019-03-01)

Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats
by: Long Li, et al.
Published: (2015-03-01)

Fatty liver in a child: Looking beyond nonalcoholic fatty liver disease
by: Jaya Agarwal, et al.
Published: (2021-01-01)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
by: Wang Xin, et al.
Published: (2011-12-01)

Nonalcoholic fatty liver disease in children and adolescents
by: Hae Sang Lee
Published: (2024-02-01)